Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Understanding the Philips CPAP & BiPAP Recall Lawsuits

Sleep apnea is a sleep disorder in which breathing stops and starts repeatedly. It can potentially be a serious condition. Sufferers of sleep apnea often use sleep apnea machines like the Philips CPAP and BiPAP machines.

With the Philips BiPAP machine, the air is pumped into the person’s airways. A higher pressure is used when sleepers breathe in and a lower pressure is used when breathing out. The Philips CPAP machine provides a continuous stream of air pressure through a mask. So, basically, both machines help to keep airways open during sleep.

People who suffer from sleep apnea and use CPAP and BiPAP machines can see a significant improvement in their sleep quality, daily life, and overall well-being. However, in June 2021, Philips recalled some of its ventilator machines due to potential health risks.

Since then, many people who used Philips’ CPAP and BiPAP machines have filed lawsuits against Philips.

What is the health risk from Philips’ CPAP and BiPAP machines?

Philips recalled their two types of ventilator machines when it was discovered that the polyester-based polyurethane foam used in the devices to reduce vibration and sound had the potential to break down.

When the devices break down, black pieces of the polyester-based polyurethane foam as well as certain invisible chemicals could potentially be breathed in or even swallowed by users of the devices.

When that happens, it can result in serious conditions that require medical intervention to prevent the problems from becoming permanent.

The Philips CPAP and BiPAP Recall Lawsuit

Lawsuits against Philips have been filed in federal courts across the United States. Due to the high number, they have been consolidated into the Philips CPAP recall lawsuit.

Though, due to the high number and people continually coming forward to file lawsuits against Philips, it is not currently known just how many people have experienced health problems as a result of using the CPAP and BiPAP devices.

What should you do if you think your health has been affected by using Philips’ CPAP and BiPAP machines?

If you used one of Philips’ CPAP or BiPAP devices and have experienced health issues that you think could be related to the recalled devices, the first thing you should do is see a doctor.

It is likely you will be screened for cancers and other illnesses related to the harmful particles and chemicals emitted by the devices. You can then explore treatment options.

If it is discovered that your health issues, such as cancer, lung damage, or respiratory injuries, are caused by or related to the hazardous machines from Philips, your next step should be to call a CPAP attorney who can help you to file a defective product lawsuit against Philips and pursue financial compensation.

What health conditions can be caused by the defective Philips ventilator devices?

We have already mentioned that the defective devices from Philips can cause cancers and other health conditions like respiratory problems, but in fact, the machines can potentially cause a wide variety of cancers and other health conditions.

For instance, people who used the Philips CPAP and BiPAP machines could develop reactive airway disease, asthma, respiratory disease, or lung or pulmonary disease.

They could also potentially develop one of the following cancers:

  • Bladder cancer.
  • Bone marrow cancer.
  • Brain cancer.
  • Breast cancer
  • Esophageal cancer.
  • Lung cancer.
  • Multiple myeloma.
  • Nasal cancer.
  • Non-Hodgkin’s lymphoma.
  • Testicular cancer.
  • Thyroid cancer.
  • Tonsil cancer.

So, if you have used one of Philips’ CPAP or BiPAP devices and you believe you have developed a health condition, make sure you visit a doctor for a diagnosis.

If it is found that you have developed one of the above conditions due to using one of Philips’ machines, you should then get in touch with an attorney to pursue the compensation you deserve.



Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy